Jinbo Bio Completes 1 Billion Yuan Private Placement to Yangshengtang
Start here
Jinbo Biochemical has completed capital verification and payment for a private placement of shares worth roughly 1 billion yuan to Yangshengtang, with the transaction finalised on October 16. The placement issued 3.6072 million shares at 277.22 yuan each. Yangshengtang has additionally committed to purchasing at least another 1 billion yuan of shares on the secondary market within 18 months of the placement's completion. The company had earlier halved the fundraising target from 2 billion yuan to 1 billion yuan and dropped a planned 850 million yuan allocation for working capital, so that proceeds now focus on its humanized collagen FAST database R&D platform. What remains open is whether Yangshengtang follows through on its secondary-market purchase commitment within the stated 18-month window.
Written by a model from the reports · updated 3 hours ago
Coverage timeline
Follow the coverage to see the different angles.
- WeChatJinbo Bio Completes 1 Billion Yuan Private Placement to Yangshengtang as Funds Verified
Jinbo Biochemical's roughly 1 billion yuan private placement of shares to Yangshengtang completed capital verification and payment on October 16. Yangshengtang also committed to buying at least another 1 billion yuan of shares on the secondary market within 18 months after the placement. The issue price was 277.22 yuan per share for 3.6072 million shares; the company earlier cut the fundraising cap from 2 billion yuan to 1 billion yuan, dropping a planned 850 million yuan for working capital, to focus proceeds on its humanized collagen FAST database R&D platform.
Coverage and heat for this story
Reports so far 1·Heat now 6·Peak heat 10 (Oct 20 00:00)·Reports, 24h +1
Two panels, same clock (pointer stays in sync): top is cumulative editorial reports — only rises; last point = All reports; slope = new reports that hour. Bottom is Live-board heatIndex — 7-day participants with a 24-hour half-life, so it can fall when talk cools.
